- en: <!--yml
  id: totrans-split-0
  prefs: []
  type: TYPE_NORMAL
  zh: <!--yml
- en: 'category: 未分类'
  id: totrans-split-1
  prefs: []
  type: TYPE_NORMAL
  zh: 'category: 未分类'
- en: 'date: 2024-05-27 15:02:57'
  id: totrans-split-2
  prefs: []
  type: TYPE_NORMAL
  zh: 'date: 2024-05-27 15:02:57'
- en: -->
  id: totrans-split-3
  prefs: []
  type: TYPE_NORMAL
  zh: -->
- en: How a drug for transplant patients became known for anti-aging effect - The
    Washington Post
  id: totrans-split-4
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 如何一种用于移植患者的药物变成了以抗衰老效果而闻名 - 华盛顿邮报
- en: 来源：[https://www.washingtonpost.com/business/2024/03/15/rapamycin-longevity-drug/](https://www.washingtonpost.com/business/2024/03/15/rapamycin-longevity-drug/)
  id: totrans-split-5
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 来源：[https://www.washingtonpost.com/business/2024/03/15/rapamycin-longevity-drug/](https://www.washingtonpost.com/business/2024/03/15/rapamycin-longevity-drug/)
- en: 'To keep himself healthy into his eighth decade, David Sandler recently decided
    to go beyond his regular workouts and try something experimental: taking rapamycin,
    an unproven but increasingly popular drug to promote longevity.'
  id: totrans-split-6
  prefs: []
  type: TYPE_NORMAL
  zh: 为了保持自己健康直到八十岁，大卫·桑德勒最近决定超越常规锻炼，尝试一些实验性的新事物：服用雷帕霉素，这是一种未经证明但越来越受欢迎的促进长寿的药物。
- en: The medication has gained a large following thanks to longevity researchers
    and celebrity doctors who, citing animal studies, contend that rapamycin could
    be a game changer in the quest tofend off age-related diseases. The drugis going
    mainstream as an anti-aging treatment, even though rapamycin’s [regulatory approval](https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021083s059,021110s076lbl.pdf)
    is for treating transplant patients. There is no evidence that it can extend human
    life.
  id: totrans-split-7
  prefs: []
  type: TYPE_NORMAL
  zh: 由于长寿研究者和名人医生们援引动物研究，称雷帕霉素可能成为抵御与年龄相关疾病的游戏规则改变者，这种药物获得了大量追随者。尽管雷帕霉素的[监管批准](https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021083s059,021110s076lbl.pdf)是用于治疗移植患者，但它正在成为抗衰老治疗的主流。目前没有证据表明它可以延长人类的寿命。
